BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 29.10
+0.55 (1.93%)
Nov 13, 2026, 1:30 PM CST
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 3.87 billion as of November 13, 2026. It is the 23,870th most valuable company in the world and the 1,212th biggest in Taiwan. Its market cap has decreased by 0.96% in one year.
Market Cap
3.87B
Enterprise Value
3.03B
Revenue
12.55M
Global Rank
Country Rank
#1,212 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 3.87B, an increase of 119.26%. That is a compound annual growth rate of 19.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 3.87B | -2.30% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 4.65B |
| Sinew Pharma | 4.29B |
| Medigen Biotechnology | 4.28B |
| UnicoCell Biomed | 4.19B |
| TWi Biotechnology | 3.53B |
| Sunhawk Vision Biotech | 3.52B |
| SYN-TECH Chem. & Pharm. | 3.39B |
| Pharmosa Biopharm | 3.28B |